Ajax Therapeutics
New York, NY
Ajax is targeting hematologic malignancies with greater precision by applying state-of-the-art computational chemistry and structural biology throughout the drug discovery and development process to create best-in-class therapies for significant unmet medical needs.
ajaxtherapeutics.comCompany Details
Founded
- 2019
Employees
- Between 5 - 20 employees
Raised
- $143,000,000
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Martin Vogelbaum
Founders
- Martin Vogelbaum
Company Collections
These are collections Ajax Therapeutics is a part of. Click on the collection name to view similar companies.